RxDoctor Payments Data

Tad Titlow

Family · Henderson, TXNPI 1073725669

Payments from drug & device makers

$10,591in general payments, 2019–2025

Across 652 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$957
  • Amgen$745
  • Bayer$648
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$10,31797%
  • Education$2142%
  • Gifts$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,591 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$97,204
Medicare patients
267
Services billed
2,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide119$165,970
OzempicSemaglutide125$146,930
FarxigaDapagliflozin Propanediol73$82,237
EliquisApixaban78$78,375
XareltoRivaroxaban70$67,936
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog51$44,740
JardianceEmpagliflozin34$30,283
TrulicityDulaglutide17$27,816
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$25,394
Breo ElliptaFluticasone/Vilanterol39$19,515
Repatha SureclickEvolocumab28$17,995
Xigduo XrDapaglifloz Propaned/Metformin16$17,204
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$13,453
TrintellixVortioxetine Hydrobromide12$11,224
SynjardyEmpagliflozin/Metformin Hcl11$10,986

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,409$193,785136 claims
Novo NordiskOzempic$1,248$146,930125 claims
PfizerEliquis, Prempro$269$83,10398 claims
AstraZenecaFarxiga$957$82,23773 claims
Johnson & JohnsonXarelto$380$67,93670 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Synjardy$470$54,72157 claims
GSKTrelegy Ellipta, Breo Ellipta$317$44,90860 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$42$11,22412 claims
AbbVieLinzess$1,308$9,46718 claims
Astellas Pharma US IncMyrbetriq$213$8,36011 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$34$3,853415 claims
Arbor Pharmaceuticals, Inc.Edarbi$27$2,96912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.

Other family in Henderson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →